Suppr超能文献

在用帕菲昔布处理的人肝癌 HepG2 和神经胶质瘤 U-87 MG 细胞系中胆固醇的动态平衡和自噬通量。

Cholesterol homeostasis and autophagic flux in perifosine-treated human hepatoblastoma HepG2 and glioblastoma U-87 MG cell lines.

机构信息

Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Av. Fuentenueva s/n, Granada 18071, Spain(2).

Department of Cell Biology, Faculty of Sciences, University of Granada, Av. Fuentenueva s/n, Granada 18071, Spain(3).

出版信息

Biochem Pharmacol. 2015 Jul 1;96(1):10-9. doi: 10.1016/j.bcp.2015.04.015. Epub 2015 Apr 28.

Abstract

Perifosine exerts an antiproliferative effect on HepG2 and U-87 MG cells and also interferes with the transport of cholesterol from the plasma membrane to the endoplasmic reticulum (ER). Recently we demonstrated that exposure of U-87 MG cells to perifosine causes an accumulation of autophagosomes. We have now expanded the study to establish the molecular mechanism by which perifosine interferes with the autophagic process. Using transmission electron microscopy, we report that the treatment of HepG2 and U-87 MG cells with perifosine causes an intense cytoplasmic vacuolization identified as autophagic vesicles. The accumulation of autophagosomes induced by perifosine is due to a blockage of the autophagic flux, thereby affecting cell proliferation. Perifosine also provokes a differential ER stress response in the HepG2 and U-87 MG cell lines. We have also demonstrated a relationship between the deregulation of cholesterol transport and the inhibition of the autophagic flux prompted by perifosine. Thus our findings clearly demonstrate that perifosine impairs the autophagic flux in HepG2 and U-87 MG cells, which is related to defects in intracellular cholesterol transport. Our study is relevant for anticancer therapy because tumour cells exhibit autophagy as a pro-survival mechanism. Further research to identify the precise mechanisms of autophagy maturation and the role of cholesterol may provide new insights into the antiproliferative action of perifosine.

摘要

帕非司亭对 HepG2 和 U-87 MG 细胞有抗增殖作用,还干扰胆固醇从质膜向内质网(ER)的转运。最近,我们证明 U-87 MG 细胞暴露于帕非司亭会导致自噬体的积累。我们现在扩展了研究,以确定帕非司亭干扰自噬过程的分子机制。通过透射电子显微镜,我们报告称,用帕非司亭处理 HepG2 和 U-87 MG 细胞会导致强烈的细胞质空泡化,被鉴定为自噬小泡。帕非司亭诱导的自噬体积累是由于自噬流的阻断,从而影响细胞增殖。帕非司亭还会在 HepG2 和 U-87 MG 细胞系中引起不同的内质网应激反应。我们还证明了胆固醇运输的失调与帕非司亭诱导的自噬流抑制之间存在关系。因此,我们的研究结果清楚地表明,帕非司亭损害了 HepG2 和 U-87 MG 细胞中的自噬流,这与细胞内胆固醇运输的缺陷有关。我们的研究与癌症治疗有关,因为肿瘤细胞表现出自噬作为一种生存机制。进一步研究以确定自噬成熟的精确机制和胆固醇的作用,可能为帕非司亭的抗增殖作用提供新的见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验